Eucrisa (generic name: crisabole) is a 100% steroid-free ointment for people with mild-to-moderate atopic dermatitis (eczema). It can be prescribed for adults and pediatric patients three months of age and older.Â
Crisaborole acts deep within skin cells to target PDE4 (phosphodiesterase 4). It is a PDE4 inhibitor.
Dosage
Follow the doctor’s instructions and refer to the enclosed Patient Information leaflet for more information.
The standard dosage is to apply a thin layer twice daily to affected areas. Once the desired clinical effect is achieved, a doctor may reduce the dosage to once daily.
Eucrisa is for topical (external) use only. Do not use it in the eyes, mouth, or vagina.
Some people have reported skin sensations such as burning or stinging at the application site. If this persists or worsens, consult with a healthcare provider.
Reactions such as contact urticaria (hives), severe itching, swelling, and abnormal redness at the application site or another site may be symptoms of hypersensitivity to crisabole. If these occur, discontinue Eucrisa immediately and consult with a healthcare provider, informing them that crisabole has been used.
Please note that not all possible side effects can be listed. If you experience any of these or any other unexpected side effects, seek medical attention promptly.Â
Symptoms of atopic dermatitis (eczema) include severe itching, red and dry patches of skin, rashes that may ooze, weep a clear fluid, or bleed when scratched. Eczema is visible on the skin’s surface, but there may also be irritation below that can’t be seen. Eucrisa works both above and below the skin to treat eczema.
